Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Aryeh Jason sold 5,000 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 5 to Jun 11, 2026 · Filed Jun 12, 2026
From Jun 5 to Jun 11, 2026, Aryeh Jason (Director) sold 5,000 Ligand Pharmaceuticals Incorporated shares at US$250.00 for US$1.25M, leaving 102,580 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$250.00
- Value
- US$1.25M
- Holding after
- 102,580 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 836 | 107,580 | Direct | |
| Jun 10, 2026 | Common Stock | Sale | 500 | US$250.00 | 107,080 | Direct |
| Jun 11, 2026 | Common Stock | Sale | 4,500 | US$250.00 | 102,580 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Aryeh Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Aryeh Jason · Nov 12, 2026
- Form 4 · Aryeh Jason · Nov 6, 2026
- Form 4 · Aryeh Jason · Nov 3, 2026
- Form 4 · Kozarich John W · Nov 16, 2026
- Form 4 · Zimmermann Martine · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Schedule 13G/A · Invesco Ltd. · Nov 10, 2026
- Form 4 · Reardon Andrew · Nov 4, 2026